Form 8-K - Current report:
SEC Accession No. 0001144204-16-135644
Filing Date
2016-11-21
Accepted
2016-11-21 17:00:27
Documents
3
Period of Report
2016-11-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v453533_8-k.htm 8-K 19060
2 EXHIBIT 99.1 v453533_ex99-1.htm EX-99.1 99597
3 GRAPHIC logo.jpg GRAPHIC 6776
  Complete submission text file 0001144204-16-135644.txt   129246
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 162010897
SIC: 2834 Pharmaceutical Preparations